Pricing Log in Create free account

Seaport Therapeutics, Inc (SPTX) vs Verastem, Inc. (VSTM)

Seaport Therapeutics, Inc and Verastem, Inc. are both Biotechnology companies. Seaport Therapeutics, Inc and Verastem, Inc. are of similar size ($1.1B and $1.1B). Seaport Therapeutics, Inc has the higher net margin (0.00% vs −178.4%) and the lower return on invested capital (−88.1% vs 0.00%). Across the 13 metrics below, Seaport Therapeutics, Inc leads on 9 and Verastem, Inc. on 4.

Valuation

Metric SPTX VSTM Biotechnology median
P/E n/m n/m 10.60
P/S n/m 8.51 9.40
P/B 2.85 84.49 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 7.98 9.02
Earnings yield (107.07%) (21.95%) (32.88%)
Free cash flow yield (8.47%) (18.70%) (23.13%)

Profitability

Metric SPTX VSTM Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% (193.73%) 0.00%
Net margin 0.00% (178.38%) 0.00%
Free cash flow margin 0.00% (159.10%) 0.00%
Return on equity (74.36%) 6,595.50% (51.96%)
Return on assets (37.78%) (88.02%) (46.06%)
Return on invested capital (88.12%) 0.00% 0.00%

Growth

Metric SPTX VSTM Biotechnology median
Revenue growth (TTM) — 286.13% 6.76%
EPS growth (last fiscal year) 36.55% 17.49% 29.88%
Revenue growth, 5-year CAGR — 12.11% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric SPTX VSTM Biotechnology median
Debt to equity 0.00 11.82 0.00
Current ratio 17.48 1.93 4.97
Net debt to EBITDA 2.42 0.76 1.01

Dividend

Metric SPTX VSTM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SPTX VSTM Biotechnology median
Market cap 1.09b 1.14b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack